These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 19203380)

  • 1. Improving survey methods in sero-epidemiological studies of injecting drug users: a case example of two cross sectional surveys in Serbia and Montenegro.
    Judd A; Rhodes T; Johnston LG; Platt L; Andjelkovic V; Simić D; Mugosa B; Simić M; Zerjav S; Parry RP; Parry JV
    BMC Infect Dis; 2009 Feb; 9():14. PubMed ID: 19203380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
    Rhodes T; Platt L; Judd A; Mikhailova LA; Sarang A; Wallis N; Alpatova T; Hickman M; Parry JV
    Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCV infection prevalence lower than expected among 18-40-year-old injection drug users in San Diego, CA.
    Garfein RS; Rondinelli A; Barnes RF; Cuevas J; Metzner M; Velasquez M; Rodriguez D; Reilly M; Xing J; Teshale EH
    J Urban Health; 2013 Jun; 90(3):516-28. PubMed ID: 22766605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of HIV and other infections and correlates of needle and syringe sharing among people who inject drugs in Podgorica, Montenegro: a respondent-driven sampling survey.
    Lausevic D; Begic S; Mugosa B; Terzic N; Vratnica Z; Labovic I; Bozicevic I
    Harm Reduct J; 2015 Feb; 12():2. PubMed ID: 25884194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alarming epidemics of human immunodeficiency virus and hepatitis C virus among injection drug users in the northwestern bordering state of Punjab, India: prevalence and correlates.
    Panda S; Roy T; Pahari S; Mehraa J; Sharma N; Singh G; Singh J; Joseph F; Singh S; Sharma NM
    Int J STD AIDS; 2014 Jul; 25(8):596-606. PubMed ID: 24352120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus infection and related risk factors among injection drug users in Montenegro.
    Baćak V; Laušević D; Mugoša B; Vratnica Z; Terzić N
    Eur Addict Res; 2013; 19(2):68-73. PubMed ID: 23006531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study.
    Rhodes T; Platt L; Maximova S; Koshkina E; Latishevskaya N; Hickman M; Renton A; Bobrova N; McDonald T; Parry JV
    Addiction; 2006 Feb; 101(2):252-66. PubMed ID: 16445554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria.
    Tun W; Vu L; Adebajo SB; Abiodun L; Sheehy M; Karlyn A; Njab J; Ahonsi B; Issa BK; Idogho O
    Int J STD AIDS; 2013 Aug; 24(8):619-25. PubMed ID: 23970571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
    Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
    BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalences and associated risk factors of HCV/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan.
    Yen YF; Yen MY; Su LW; Li LH; Chuang P; Jiang XR; Deng CY
    BMC Public Health; 2012 Dec; 12():1066. PubMed ID: 23227904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
    Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
    Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.
    McFall AM; Solomon SS; Lucas GM; Celentano DD; Srikrishnan AK; Kumar MS; Mehta SH
    Addiction; 2017 Aug; 112(8):1480-1487. PubMed ID: 28317210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of hepatitis C viremia vs. antibody alone on transmission among male injecting drug users in three Afghan cities.
    Nasir A; Todd CS; Stanekzai MR; Bautista CT; Botros BA; Scott PT; Kim JH; Strathdee SA; Tjaden J
    Int J Infect Dis; 2011 Mar; 15(3):e201-5. PubMed ID: 21190883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations.
    Removille N; Origer A; Couffignal S; Vaillant M; Schmit JC; Lair ML
    BMC Public Health; 2011 May; 11():351. PubMed ID: 21595969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the sociodemographic and behavioural factors associated with hepatitis C virus testing amongst people who inject drugs in England, Wales and Northern Ireland: A quantitative cross-sectional analysis.
    Yuan JM; Croxford S; Viviani L; Emanuel E; Phipps E; Desai M
    Int J Drug Policy; 2022 Nov; 109():103821. PubMed ID: 35994940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk behaviors, prevalence of HIV and hepatitis C virus infection and population size of current injection drug users in a China-Myanmar border city: results from a Respondent-Driven Sampling Survey in 2012.
    Li L; Assanangkornchai S; Duo L; McNeil E; Li J
    PLoS One; 2014; 9(9):e106899. PubMed ID: 25203256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City.
    Des Jarlais DC; Arasteh K; McKnight C; Hagan H; Perlman D; Friedman SR
    Drug Alcohol Depend; 2009 Apr; 101(1-2):88-91. PubMed ID: 19108958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
    Neaigus A; Zhao M; Gyarmathy VA; Cisek L; Friedman SR; Baxter RC
    J Urban Health; 2008 May; 85(3):309-22. PubMed ID: 18340537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
    Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF
    BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.